Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0552
D

Failure to Obtain and Renew Informed Consent for Psychotropic Medications

Westminster, California Survey Completed on 07-01-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that residents and their responsible parties were fully informed and provided with appropriate, timely, and specific informed consent regarding the use of psychotropic medications. Multiple residents, including those with significant mental health diagnoses and those lacking capacity to make their own medical decisions, did not have their informed consents renewed every six months as required. In several cases, the consent forms did not specify the exact dose, frequency, or reasons for prescribing the medications, and the process for obtaining consent did not consistently involve direct communication between the prescribing physician and the resident's conservator or responsible party. For one resident with bipolar disorder, anxiety disorder, and substance use disorder, who had conservators for medical decisions, the medication consent form only listed medication names and dosage ranges, omitting the specific dose, frequency, and indications as required. The conservator confirmed that the physician did not directly contact them to obtain informed consent, and the process relied on faxed forms or verbal consent via nursing staff, without adequate explanation of the medications. The physician acknowledged that their signature on the consent form only verified the medication list and dosage range, not that informed consent had been properly obtained. Other residents, including those with no capacity to make decisions, were also affected. Informed consents for psychotropic medications such as risperidone, Lexapro, Belsomra, Seroquel, and Remeron were not renewed after six months, and facility policy and procedure documents had not been updated to reflect the new regulatory requirements for six-month renewals. Nursing staff and the DON confirmed that the required renewals had not occurred, and that the facility's tracking and policy review processes were insufficient to ensure compliance. These failures were identified through interviews, medical record reviews, and policy reviews, and were acknowledged by facility staff.

An unhandled error has occurred. Reload 🗙